Cargando…

Retro-inverso follicle-stimulating hormone peptide-mediated polyethylenimine complexes for targeted ovarian cancer gene therapy

Background: The development of nanoparticle drug delivery systems with targeted ligands has the potential to increase treatment efficiency in ovarian cancer. Methods: We developed a 21-amino acid peptide, YTRDLVYGDPARPGIQGTGTF (L-FP21) conjugated to polyethylenimine (PEI) and methoxy polyethylene gl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Mengyu, Zhang, Mingxing, Wang, Jing, Cai, Qingqing, Zhao, Ran, Yu, Yi, Tai, Haiyan, Zhang, Xiaoyan, Xu, Congjian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058519/ https://www.ncbi.nlm.nih.gov/pubmed/29667478 http://dx.doi.org/10.1080/10717544.2018.1461956

Ejemplares similares

Recent Applications of Retro-Inverso Peptides
por: Doti, Nunzianna, et al.
Publicado: (2021)

A retro-inverso cell-penetrating peptide for siRNA delivery
por: Vaissière, Anaïs, et al.
Publicado: (2017)

Enhanced antitumor effects of follicle-stimulating hormone receptor-mediated hexokinase-2 depletion on ovarian cancer mediated by a shift in glucose metabolism
por: Zhang, Meng, et al.
Publicado: (2020)

Retro-inverso Urokinase Receptor Antagonists for the Treatment of Metastatic Sarcomas
por: Carriero, Maria Vincenza, et al.
Publicado: (2017)

Novel Retro-Inverso Peptide Antibiotic Efficiently Released by a Responsive Hydrogel-Based System
por: Cesaro, Angela, et al.
Publicado: (2022)

Retro-Inverso Carbohydrate Mimetic Peptides with Annexin1-Binding Selectivity, Are Stable In Vivo, and Target Tumor Vasculature
por: Chen, Xinyi, et al.
Publicado: (2013)

Targeted gene silencing using a follicle-stimulating hormone peptide-conjugated nanoparticle system improves its specificity and efficacy in ovarian clear cell carcinoma in vitro
por: Hong, Shanshan, et al.
Publicado: (2013)

Viaje inverso
por: Carrera, Gustavo Luis
Publicado: (1977)

A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease
por: Parthsarathy, Vadivel, et al.
Publicado: (2013)

Caminos inversos : vivencias de ciencia y guerra /
por: Méndez, Rafael
Publicado: (1987)

Correction: A Novel Retro-Inverso Peptide Inhibitor Reduces Amyloid Deposition, Oxidation and Inflammation and Stimulates Neurogenesis in the APPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease
por: Parthsarathy, Vadivel, et al.
Publicado: (2013)

The Effects of Side-Chain Configurations of a Retro–Inverso-Type Inhibitor on the Human T-Cell Leukemia Virus (HTLV)-1 Protease
por: Awahara, Chiyuki, et al.
Publicado: (2022)

Efficacy of inverso isomer of CendR peptide on tumor tissue penetration
por: Wang, Ruifeng, et al.
Publicado: (2018)

Novel multi-component nanopharmaceuticals derived from poly(ethylene) glycol, retro-inverso-Tat nonapeptide and saquinavir demonstrate combined anti-HIV effects
por: Wan, Li, et al.
Publicado: (2006)

Profile of follicle-stimulating hormone and polymorphism of follicle-stimulating hormone receptor in Madrasin cattle with ovarian hypofunction
por: Utomo, Budi, et al.
Publicado: (2020)

Diccionario inverso de la lengua española
por: Bosque, Ignacio
Publicado: (1987)

Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells
por: Yu, Yi, et al.
Publicado: (2014)

Assessment of ovarian reserve: Anti-Mullerian hormone versus follicle stimulating hormone
por: Jamil, Zehra, et al.
Publicado: (2016)

Synergistic effects of combined platelet-activating factor receptor and epidermal growth factor receptor targeting in ovarian cancer cells
por: Yu, Yi, et al.
Publicado: (2014)

Epidermal growth factor induces platelet-activating factor production through receptors transactivation and cytosolic phospholipase A(2) in ovarian cancer cells
por: Yu, Yi, et al.
Publicado: (2014)

Association of follicle stimulating hormone receptor promoter with ovarian response in IVF-ET patients
por: Dan, Wang, et al.
Publicado: (2015)

Luteinizing hormone and follicle stimulating hormone synergy: A review of role in controlled ovarian hyper-stimulation
por: Raju, Gottumukkala Achyuta Rama, et al.
Publicado: (2013)

The Clinical Efficacy of Three Different Follicle-Stimulating Hormones for Follicle Growth and Development in Long-Protocol Controlled Ovarian Hyperstimulation Treatment
por: Zhang, Xi-Qian, et al.
Publicado: (2021)

The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles
por: Yang, Chunxia, et al.
Publicado: (2022)

Advances in the Regulation of Mammalian Follicle-Stimulating Hormone Secretion
por: Wang, Hao-Qi, et al.
Publicado: (2021)

Development of Follicle-Stimulating Hormone Receptor Binding Probes to Image Ovarian Xenografts
por: Lee, Chung-Wein, et al.
Publicado: (2015)

Transcriptional control of the MUC16 promoter facilitates follicle-stimulating hormone peptide-conjugated shRNA nanoparticle-mediated inhibition of ovarian carcinoma in vivo
por: Zhang, Ming-Xing, et al.
Publicado: (2018)

The ratio of exogenous Luteinizing hormone to Follicle stimulating hormone administered for controlled ovarian stimulation is associated with oocytes’ number and competence
por: Albu, Dragos, et al.
Publicado: (2020)

Tumor-directed gene therapy in mice using a composite nonviral gene delivery system consisting of the piggyBac transposon and polyethylenimine
por: Kang, Yu, et al.
Publicado: (2009)

Follicle-Stimulating Hormone Alleviates Ovarian Aging by Modulating Mitophagy- and Glycophagy-Based Energy Metabolism in Hens
por: Dong, Juan, et al.
Publicado: (2022)

Role of Follicle-Stimulating Hormone in Spermatogenesis
por: Oduwole, Olayiwola O., et al.
Publicado: (2018)

Autoimmunity to the Follicle-Stimulating Hormone Receptor (FSHR) and Luteinizing Hormone Receptor (LHR) in Polycystic Ovarian Syndrome
por: Schniewind, Hanna A., et al.
Publicado: (2021)

OR24-04 Ovarian Follicle Survival Is Determined by Follicle-Stimulating Hormone Receptor (FSHR) and Estrogen Receptor (GPER) Heteromers
por: Casarini, Livio, et al.
Publicado: (2020)

Follicle-stimulating hormone peptide-conjugated nanoparticles for targeted shRNA delivery lead to effective gro-α silencing and antitumor activity against ovarian cancer
por: Hong, Shan-Shan, et al.
Publicado: (2018)

The potential of follicle-stimulating hormone peptide-modified triptolide-loaded nanoparticles to induce a mouse model of premature ovarian insufficiency
por: Chen, Xiu-Ying, et al.
Publicado: (2015)

Hormonal Regulation of Follicle-Stimulating Hormone Glycosylation in Males
por: Campo, Stella, et al.
Publicado: (2019)

Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation
por: Wang, Jie, et al.
Publicado: (2015)

The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation
por: Nenonen, Hannah A., et al.
Publicado: (2019)

Live birth after letrozole as an adjunct to follicle-stimulating hormone versus follicle-stimulating hormone alone for ovarian stimulation in in vitro fertilisation cycles—study protocol for a randomised controlled trial
por: Guo, Wei, et al.
Publicado: (2022)

Mechanism of hormone and allosteric agonist mediated activation of follicle stimulating hormone receptor
por: Duan, Jia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tho04l496ohiapag242qhjoh4l